SCHEMBL12427720

SCHEMBL12427720

Cc1nc(-c2ccccc2)ccc1C=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
RAB9A P51151 2/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
KDM4E B2RXH2 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.42
TSHR P16473 1/20 0.42
LMNA P02545 2/20 0.41
TDO2 P48775 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ERN1 O75460 1/20 0.41
HSD17B10 Q99714 1/20 0.41
RXFP1 Q9HBX9 1/20 0.40
NPC1 O15118 1/20 0.40
PDGFRB P09619 1/20 0.40
KDR P35968 1/20 0.40
FLT3 P36888 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28519763 0.81 KMT2A (0.45) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL4799732 0.79 SQOR (0.49) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL30772447 0.79 SQOR (0.49) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL1549511 0.78 RAD51 (0.41) ALDH1A1SMN1; SMN2GAANPC1
SCHEMBL1549312 0.77 KDM1A (0.56) ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL12427715 0.76 SQOR (0.46) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL28133225 0.76 ALDH1A1 (0.46) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL13299549 0.75 ALDH1A1 (0.58) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL12427717 0.75 NPSR1 (0.40) ALDH1A1RAB9AMEN1KMT2AKDM4E
SCHEMBL14931777 0.75 ALDH1A1 (0.58) ALDH1A1RAB9AMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461183-B2 PPAR agonist compounds, preparation and uses GENFIT (FR) 2013-06-11 US disclosed
US-20110195993-A1 PPAR AGONIST COMPOUNDS, PREPARATION AND USES GENFIT (FR) 2011-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110195993-A1 PPAR AGONIST COMPOUNDS, PREPARATION AND USES PPARD, PPARA, PPARG ALDH1A1 1483/4885RAB9A 2825/4885MEN1 4851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.